Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Insmed Incorporated(INSM) | 3,541,095 | 10,497,277 | +6,956,182 | $237.08M | $766.30M | 62.31% | +$529.22M |
| Vaxcyte, Inc.(PCVX) | 2,080,946 | 2,198,187 | +117,241 | $163.92M | $251.19M | 20.43% | +$87.27M |
| Geron Corporation(GERN) | 23,915,480 | 22,038,773 | -1,876,707 | $106.18M | $100.06M | 8.14% | -$6.13M |
| Keros Therapeutics, Inc.(KROS) | 1,525,902 | 1,523,732 | -2,170 | $68.77M | $88.48M | 7.20% | +$19.71M |
| Summit Therapeutics Inc.(SMMT) | 0 | 1,084,880 | +1,084,880 | $0 | $23.76M | 1.93% | +$23.76M |
| Avidity Biosciences Inc | 200,000 | 0 | -200,000 | $8.11M | $0 | — | -$8.11M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 325,140 | 0 | -325,140 | $14.27M | $0 | — | -$14.27M |
| Cytokinetics, Incorporated(CYTK) | 4,575,558 | 0 | -4,575,558 | $246.07M | $0 | — | -$246.07M |
| Elevation Oncology Inc | 1,916,290 | 0 | -1,916,290 | $4.81M | $0 | — | -$4.81M |
| Spyre Therapeutics, Inc.(SYRE) | 452,040 | 0 | -452,040 | $10.27M | $0 | — | -$10.27M |